| 5375 |
Centers for Disease Control and Prevention |
Html |
en |
FASD - Treatments |
FASDs are 100% preventable if a woman does not drink alcohol during pregnancy. There is no known safe amount of alcohol to drink while pregnant. There is also no safe time during pregnancy to drink and no safe kind of alcohol. |
| challenging FASD behaviors2 | 0.757842 |
| mental health | 0.775112 |
| stable home environment | 0.713203 |
| age-appropriate social skills | 0.723364 |
| FASD State Systems | 0.757565 |
| Neurocognitive habilitation therapy | 0.724024 |
| interactive learning experience | 0.807207 |
| subtle social skills | 0.721666 |
| local support groups | 0.707852 |
| children | 0.892251 |
| child many skills | 0.717521 |
| social services | 0.759573 |
| math interactive learning | 0.807219 |
| intervention treatment services | 0.853655 |
| early intervention treatment | 0.843351 |
| E. Socio-cognitive habilitation | 0.710463 |
| personal medical questions | 0.737578 |
| appropriate educational classes | 0.721597 |
| behavior support techniques | 0.732404 |
| Creative art therapy | 0.709743 |
| weekly sessions | 0.713467 |
| social skills | 0.756506 |
| fetal alcohol spectrum | 0.842815 |
| behavior problems | 0.724392 |
| stable home life | 0.712845 |
|
| child | 0.967674 |
| FASD Fall Conference | 0.752164 |
| behavior management specialist | 0.727593 |
| FASD symptoms | 0.73541 |
| Early diagnosis | 0.71758 |
| FASD Center | 0.70664 |
| child development | 0.724707 |
| appropriate social skills1 | 0.721928 |
| high energy levels | 0.709599 |
| mental health providers | 0.711778 |
| learning experience program | 0.712821 |
| special education | 0.754651 |
| Alcohol Clin Exp | 0.706179 |
| FASDs | 0.87951 |
| Special education programs | 0.728756 |
| child psychiatrist | 0.717007 |
| early intervention | 0.885085 |
| FASD | 0.77271 |
| Early intervention services | 0.785065 |
| alcohol spectrum disorders | 0.844059 |
| neurocognitive habilitation program | 0.720915 |
| Mental Health Services | 0.727662 |
| child talk | 0.736696 |
| Primary care provider | 0.721423 |
|
CLICK HERE |
| 6144 |
Centers for Disease Control and Prevention |
Html |
en |
Breastfeeding Report Card-United States, 2008 |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7996 |
Centers for Disease Control and Prevention |
Html |
es |
Preventing Chronic Disease - CDC: Volume 10, 2013: 12_0067 |
Volumen 10 — el 10 de enero de 2013. |
| Rao C | 0.846629 |
| medianos recursos | 0.811467 |
| Marks G | 0.866659 |
| mujeres vietnamitas | 0.745338 |
|
| alta proporción | 0.704894 |
| Nhung NT | 0.866619 |
| Estados Unidos | 0.630583 |
| Hoa NP | 0.918553 |
|
CLICK HERE |
| 10075 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH Program Portfolio : Immune, Dermal and Infectious Diseases : Program Description |
The mission of the NIOSH research program for Immune, Dermal & Infectious Diseases is to eliminate occupational injuries, illnesses, and fatalities among workers in these industries through a focused program of research and prevention. Primary efforts are focused on hazard identification since when potential hazards are recognized, work-related dermal and immune diseases can often be prevented or their effects minimized. |
| dermal diseases | 0.460508 |
| list Skip | 0.705785 |
| Infectious Disease Prevention | 0.591708 |
| trade associations | 0.324699 |
|
| Immune | 0.2227 |
| page options Skip | 0.906266 |
| professional organizations | 0.323529 |
| navigation Skip | 0.721193 |
|
CLICK HERE |
| 11048 |
Centers for Disease Control and Prevention |
Html |
en |
Botulism Associated with Home-Fermented Tofu in Two Chinese Immigrants — New York City, March–April 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| Similar fermentation practices | 0.46348 |
| cranial nerve deficits | 0.512793 |
| stool specimens | 0.511785 |
| toxin production | 0.468331 |
| foodborne botulism | 0.725444 |
| New York City | 0.56128 |
| bulk tofu | 0.774921 |
| tofu manufacturing facility | 0.58481 |
| toxin formation | 0.470496 |
| foodborne botulism cases | 0.558035 |
| Clostridium botulinum spores | 0.474604 |
| Public health responders | 0.508236 |
| botulinum toxin | 0.675248 |
| bacterium Clostridium botulinum | 0.471628 |
| Alaska Native foods | 0.50144 |
| York City borough | 0.462248 |
| traditional fermented Alaska | 0.526492 |
| botulinum antitoxin | 0.477178 |
| fermented tofu | 0.657528 |
| cranial nerve palsies | 0.609086 |
| C. botulinum spores | 0.47367 |
| public health response | 0.460175 |
| deep tendon reflexes | 0.622459 |
| leftover tofu | 0.56037 |
| extremity deep tendon | 0.462163 |
|
| room temperature | 0.477002 |
| probable case | 0.490807 |
| Clostridium botulinum | 0.4762 |
| United States | 0.624666 |
| myasthenia gravis | 0.485719 |
| fermented Alaska Native | 0.526485 |
| fresh tofu | 0.64417 |
| Public Health Investigation | 0.463739 |
| upper extremity weakness | 0.509821 |
| similar recipes | 0.460087 |
| bilateral cranial nerve | 0.680866 |
| edrophonium chloride test | 0.506631 |
| Chinese grocery | 0.474049 |
| water-filled bins | 0.463298 |
| home-fermented tofu | 0.910591 |
| public health | 0.556703 |
| botulinum spores | 0.476487 |
| botulinum toxin type | 0.625368 |
| oculomotor palsy | 0.462139 |
| unfermented tofu | 0.576391 |
| Electromyography studies | 0.464381 |
| York City Department | 0.464434 |
| fresh bulk tofu | 0.630174 |
| respiratory failure | 0.486882 |
|
CLICK HERE |
| 12212 |
Centers for Disease Control and Prevention |
Html |
en |
Challenges in Responding to the Ebola Epidemic - Four RuralCounties, Liberia, August-November 2014 |
On December 16, 2014, this report was posted as an MMWR Early Release on the MMWR website (http://www.cdc.gov/mmwr). |
| Sinoe health officials | 0.419488 |
| health education | 0.402233 |
| case investigation | 0.528645 |
| transportation network strategies | 0.453759 |
| Grand Bassa health | 0.468309 |
| Joel M. Montgomery | 0.38767 |
| rural counties | 0.418206 |
| district health teams | 0.403893 |
| health officials | 0.591807 |
| county health officials | 0.544274 |
| MMWR Early Release | 0.391397 |
| Social Welfare | 0.430651 |
| safe burials | 0.426224 |
| health care providers | 0.413351 |
| possible Ebola patient | 0.457266 |
| personal protective equipment | 0.452243 |
| Global Health | 0.403886 |
| Grand Bassa | 0.8279 |
| contact tracing | 0.574519 |
| Tolbert G. Nyenswah | 0.468748 |
| safe burial practices | 0.460211 |
| communication networks | 0.385624 |
| health care facilities | 0.413294 |
| Ebola patients | 0.451106 |
| counties | 0.49788 |
|
| Ebola | 0.607768 |
| Ebola response plans | 0.516169 |
| Ebola virus disease | 0.475485 |
| Ebola epidemic | 0.410367 |
| limited access | 0.385904 |
| Ebola response strategies | 0.54057 |
| possible Ebola | 0.462505 |
| Grand Cape Mount | 0.90823 |
| Cape Mount officials | 0.390041 |
| Ebola cases | 0.41892 |
| laboratory test results | 0.436634 |
| county Ebola response | 0.484338 |
| Mount health officials | 0.419588 |
| core Ebola response | 0.468841 |
| adequate training | 0.471388 |
| health care workers | 0.473654 |
| remote areas | 0.493227 |
| Global Health Protection | 0.398858 |
| county health teams | 0.686681 |
| poor road conditions | 0.429839 |
| Ebola specimens | 0.420595 |
| Jordan W. Tappero | 0.389786 |
| Ebola treatment units | 0.574337 |
| Aimee Summers | 0.391002 |
|
CLICK HERE |
| 12469 |
Centers for Disease Control and Prevention |
Video |
en |
June 2013 ACIP Meeting -- Human Papillomavirus (HPV) Vaccines |
Introduction by Dr. J Bocchini. Merck pregnancy registry for quadrivalent HPV vaccine by Dr. F Lievano. Plans for updated ACIP statement by Dr. E Dunne. HPV vaccine program and impact monitoring by Dr. L Markowitz.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at: http://streaming.cdc.gov/vod.php?id=f030e0e083784417044a1b9b75008fc820130730142723328 |
| ACIP Meeting | 0.933869 |
| Human Papillomavirus | 0.839868 |
|
| Vaccines | 0.479873 |
| YouTube | 0.478533 |
|
CLICK HERE |
| 12797 |
Centers for Disease Control and Prevention |
Html |
en |
What Is a Concussion? | HEADS UP | CDC Injury Center |
null |
| Medical providers | 0.691101 |
| traumatic brain injury—or | 0.911251 |
| type | 0.463074 |
| body | 0.461572 |
| sudden movement | 0.745908 |
| head | 0.505701 |
| chemical changes | 0.703082 |
| brain cells | 0.66952 |
|
| hit | 0.487924 |
| bump | 0.519409 |
| concussion | 0.799542 |
| skull | 0.490371 |
| jolt | 0.520119 |
| blow | 0.501105 |
| twist | 0.486888 |
|
CLICK HERE |
| 13332 |
Centers for Disease Control and Prevention |
Html |
en |
Hepatitis B Screening and Prevalence Among ResettledRefugees - United States, 2006-2011 |
Kevin C. Scott, MD1; Eboni M. Taylor, PhD2; Blain Mamo, MPH3; Nathaniel D. |
| active infection | 0.322239 |
| refugees | 0.737163 |
| data | 0.325648 |
| disease prevalence | 0.285297 |
| Minnesota Department | 0.331383 |
| active HBV infection | 0.469755 |
| refugee children | 0.296314 |
| refugee medical exam | 0.307134 |
| refugee populations | 0.389494 |
| health care providers | 0.28221 |
| past infection | 0.462153 |
| surveillance data | 0.313706 |
| refugee groups | 0.353677 |
| Kevin C. Scott | 0.342416 |
| routine childhood hepatitis | 0.281641 |
| chronic HBV infection | 0.573011 |
| hepatitis B surface | 0.295527 |
| HBV infection status | 0.481733 |
| acute infection | 0.314743 |
| chronic infection | 0.382266 |
| smaller refugee groups | 0.313857 |
| Thomas Jefferson University | 0.388305 |
| United States | 0.498898 |
| HBV antibody | 0.378874 |
|
| state refugee health | 0.334374 |
| aggregate de-identified data | 0.285895 |
| Jefferson University | 0.393358 |
| single refugee group | 0.315123 |
| chart review data | 0.287359 |
| Iraqi refugees | 0.491592 |
| Burmese refugees | 0.422361 |
| HBV exposure | 0.36198 |
| Yale-New Haven Hospital | 0.340488 |
| incorporated surveillance data | 0.285051 |
| past HBV infection | 0.637398 |
| current infection | 0.359422 |
| current HBV status | 0.412103 |
| largest refugee groups | 0.320614 |
| HBV prevalence rates | 0.477641 |
| past infection rates | 0.359906 |
| male refugees | 0.41795 |
| chronic infection benefit | 0.375202 |
| hepatitis | 0.312474 |
| HBV status | 0.418343 |
| female refugees | 0.372016 |
| chronic hepatitis | 0.294482 |
| different refugee groups | 0.313218 |
| HBV infection | 0.917528 |
|
CLICK HERE |
| 15282 |
Centers for Disease Control and Prevention |
Html |
en |
Interim Guidance on Case Definitions for Investigations of Human Infection with Highly Pathogenic Avian Influenza A H5 Viruses in the United States |
Interim Guidance on Case Definitions for Investigations of Human Infection with Highly Pathogenic Avian Influenza A H5 Viruses in the United States - CDC |
| HPAI A/H5 virus | 0.455871 |
| avian influenza | 0.567861 |
| influenza A. Specimens | 0.461518 |
| possible human infections | 0.384526 |
| positive RIDT test | 0.37403 |
| exposure criteria | 0.423102 |
| negative RIDT result | 0.368066 |
| domestic poultry | 0.343536 |
| confirmatory testing | 0.38091 |
| epidemiologic information support | 0.368196 |
| direct contact | 0.363431 |
| pathogenic avian influenza | 0.487825 |
| probable cases | 0.423846 |
| severe human illness | 0.401531 |
| HPAI A H5 | 0.490023 |
| influenza A virus | 0.45473 |
| case definitions | 0.350154 |
| seasonal influenza | 0.413562 |
| A/H5 virus infection | 0.435005 |
| commercially available ridts | 0.419969 |
| Confirmed Case definition | 0.4206 |
| H5 virus infection | 0.896505 |
| influenza real-time reverse | 0.460232 |
| influenza RT-PCR test | 0.472451 |
| public health laboratories | 0.373364 |
|
| illness onset | 0.391417 |
| HPAI A/H5 viruses | 0.453219 |
| Presumptive positive identification | 0.381982 |
| close physical contact | 0.371143 |
| influenza diagnostic test | 0.464778 |
| HPAI H5 virus | 0.988034 |
| Human Influenza Virus | 0.513812 |
| Asian-origin HPAI A/H5 | 0.39371 |
| United States | 0.423069 |
| influenza-like illness | 0.352662 |
| HPAI H5N1 virus | 0.451939 |
| laboratory test results | 0.440781 |
| wild birds | 0.347511 |
| Probable Case | 0.357735 |
| Influenza Division Laboratory | 0.46777 |
| influenza virus infection | 0.514375 |
| animal influenza | 0.414223 |
| local health departments | 0.380784 |
| polymerase chain reaction | 0.373715 |
| Unprotected exposure | 0.343118 |
| recent close contact | 0.372284 |
| HPAI H5 viruses | 0.511892 |
| presumptive positive cases | 0.448838 |
| Real-Time RT-PCR Diagnostic | 0.381607 |
|
CLICK HERE |